StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)

Close on Nov 18, 2026Market cap $155.75MP/E –Yield –

Korsana Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Korsana Biosciences's pe ratio was 16.9× on Oct 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 202416.9×–

More Korsana Biosciences figures

See a number that looks wrong?